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1. Introduction
   Many herbal products have been prescribed for the 
management of diabetes mellitus in ancient and recent 
literature[1]. Herbal medicines are popularly used 
remedies for many diseases by a vast majority of the 
world’s population, because allopathic medicines have 
large number of side-effects. Thus, herbal formulations 
have attained widespread acceptability as therapeutic 
agents in many developing countries as anti-diabetics, 
hepatoprotective and lipid lowering agents[2-4]. Whereas 
a number of plants used in folk medicine have indeed 
been scientifically confirmed to possess such activity, 
many others, including Tetrapleura tetraptera (Schum and 
Thonn) Taub (T. tetraptera) used in the traditional medicine 
by the Igala people of north central Nigeria, are yet to be 
validated.  
   T. tetraptera, a popular medicinal plant belonging to the 
family Fabaceae (formerly Leguminosae: Mimosoideae), 
is commonly known as “Aridan” or “Aidan” among the 
Yoruba ethnic group of South Western Nigeria, “Abogolo” 
among the Igala people of north central Nigeria, and “Dawo” 
among the Hausa people of Northern Nigeria. It is generally 
found in the lowland forest of many tropical African 
countries, and known to have fruit that consists of fleshy 
pulp and small, brownish-black seeds, a characteristic 
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fragrant and pungent aromatic odor[5]. It is used as a popular 
seasoning spice in Southern and Eastern Nigeria[6], and its 
fruit is used for the management of convulsions, leprosy, 
inflammation, rheumatism, flatulence, jaundice and 
fevers, as well as the management and control of adult-
onset type 2 diabetes mellitus[5,6]. Previous studies in our 
laboratory showed that the methanolic extract of the leaf of 
this plant has antioxidant effect on carbon tetrachloride-
induced hepatotoxicity[7], while the aqueous fruit extract 
has been shown to possess hypoglycemic properties[8]. 
However, information on the scientific validation of the 
leaves of T. tetraptera for management of diabetes and the 
associated complications appears to be lacking. Therefore, 
this study was undertaken to investigate the ameliorative 
role of T. tetraptera leaves in hyperglycemia with associated 
conditions like oxidative stress, kidney damage and 
disorders in lipid metabolism. 
2. Materials and methods 
2.1. Sample collection and identification  
   The leaves of T. tetraptera were collected from Emere 
in Ankpa Local Government Area of Kogi State, Nigeria in 
August, 2010. The plant was identified at the Herbarium Unit 
of the Nigerian Institute for Pharmaceutical Research and 
Development, Idu, Abuja, Nigeria, where a voucher number 
5881 was assigned.
2.2. Sample preparation and extraction
   The leaves of T. tetraptera were dried in the laboratory at 
room temperature, following initial drying in the morning 
sun for 4 h on the first day to arrest enzymatic deterioration, 
before pulverization using laboratory mortar and pestle. 
Pulverized material (35 g) was placed in the thimble of 
Soxhlet extractor and extracted first using petroleum ether 
(300 mL) for 8 h each (to remove the lipid content) and then 
methanol (300 mL), three times for 5 h each. The methanol 
extracts were combined and dried in vacuo at 45 °C using a 
rotary evaporator (Büchi Labortechnik AG, Switzerland)[2,9,10].
2.3. Animal management
   Wistar strain of male albino rats with body weight ranging 
from 160-200 g were used for the study. The rats were bred in 
the Animal House of Department of Biochemistry, Ahmadu 
Bello University, Zaria. The rats were fed on pelleted 
commercial growers mash (Vital Feeds, Jos, Nigeria). They 
were kept at room temperature and maintained ad libitum 
on tap water and growers mash (ECWA Feeds, Bukuru-Jos, 
Plateau State, Nigeria), except in the last 12-15 h before 
termination of the experiment. The animals were housed in 
plastic cages under conditions of 12 h light/12 h dark cycle 
at 25 °C. The rats were weighed prior to commencement and 
termination of the experiment[2,9,11]. 
2.4. Induction of diabetes and experimental grouping
   Diabetes mellitus was induced in rats by intraperitoneal 
injection of freshly prepared alloxan monohydrate solution 
dissolved in normal saline (120 mg/kg), followed 48 h later 
by a booster dose of 100 mg/kg. After the booster dose for 3 
d, fasting blood glucose was measured and rats with blood 
glucose levels above 140 mg/dL were considered diabetic 
and included in the study. 
   Five groups of five rats each were allocated to the 
following intraperitoneal treatment schedule for 7 d: 
untreated normal control, untreated alloxan-diabetic 
control, diabetic rats treated with glibenclamide, normal 
rats treated with extract and diabetic rats treated with the 
extract. The extract was administered at a dose of 50 mg/
kg, while the standard glibenclamide was administered at a 
dose of 1 mg/kg.
2.5. Collection of blood sample and blood glucose 
determination
   Blood samples were drawn from tail tip of each rat fasted 
overnight on Day 0 and Day 7 (i.e. one week) for estimation 
of fasting blood glucose, following which the body weight 
measurement was taken. Blood glucose estimation was 
done by one touch electronic glucometer using glucose 
test strips. On Day 7, after blood was collected for fasting 
blood sugar determination, animals were placed under mild 
chloroform anesthesia before sacrifice[12].
2.6. Animal sacrifice
   All rats were sacrificed 24 h following last administration 
of drug or T. tetraptera extract. Animals were sacrificed 
under chloroform anesthesia and whole blood was 
collected and allowed to stand for 2 h before collection 
of serum for assay for biochemical parameters. All serum 
samples were kept in Eppendorf tubes and stored at 
-20 °C. The organs were immediately harvested, rapidly 
rinsed in ice-cold normal saline and stored at -20 °C for 
analysis of malondialdehyde (MDA) as indicator of lipid 
peroxidation[2,9,11].
2.7. Tissue homogenization
   The whole liver, kidneys and heart from each rat were 
removed after sacrificing the animal, and were rinsed in 
normal saline and immediately stored in deep freezer. 
Tissues were homogenized in 10 parts in ice-cold potassium 
phosphate buffer (pH 7.4) using mortar and pestle. The 
homogenate was centrifuged at 3 000 伊g for 15 min and the 
supernatant was collected. Protein concentration of the 
sample was determined by Biuret method using bovine 
serum albumin as standard[2,9,11].
2.8. Assay for lipid peroxidation
   Lipid peroxidation was determined as thiobarbituric acid-
reactive substances as described by Torres et al. based 
on the principle that peroxide intermediates generated 
released MDA upon cleavage[13]. This compound reacted 
with thiobarbituric acid to form a coloured complex that 
was measured at 535 nm. one milliliter of 14% trichloroacetic 
acid was measured into a test tube, 1 mL thiobarbituric acid 
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(0.67%) was added and 50 µL of the tissue homogenate was 
added. The mixture was incubated at 80 °C for 30 min in 
a water bath, and then allowed to cool rapidly in ice for 5 
min, followed by centrifugation at 3000 rpm for 10 min. MDA 
was measured colorimetrically at 535 nm and the level of 
lipid peroxidation was calculated using the molar extinction 
coefficient of MDA[2,9,11].
2.9. Determination of the activity of endogenous antioxidant 
enzymes
   The ability of the extracts to boost the capacity of 
antioxidant enzymes was evaluated by determining the 
activity of two endogenous antioxidant enzymes, namely, 
catalase (CAT) and superoxide dismutase (SOD) as follows.
2.9.1. Catalase
   CAT activity was measured using the procedure reported 
by Abei Briefly[14]. A total of 10 µL of serum was added to 
test tube containing 2.8 mL of 50 mmol/L phosphate buffer 
(pH 7.0). The reaction was initiated by adding 0.1 mL of 
fresh 30 mmol/L H2O2 and the decomposition rate of H2O2 
was measured at 240 nm for 5 min on a spectrophotometer 
(Jenway 640 UV/Vis). A molar extinction coefficient of 0.041 1 
mmol/L/cm was used to calculate CAT activity.
2.9.2. Superoxide dismutase
   SOD activity was evaluated according to the method 
described by Martin et al[15]. Exactly 920 µL of assay buffer 
was added into clean test tube containing 40 µL of sample, 
mixed and incubated for 2 min at 25 °C, following which 40 
µL of hematoxylin solution was added, mixed quickly and 
the absorbance was measured immediately at 560 nm.
2.10. Determination of liver function parameters
   Aspartate aminotransferase (AST)  and alanine 
aminotransferase (ALT) were determined colorimetrically 
at 546 nm using Randox assay kits based on the principle 
first described by Reitman and Frankel[16]. Also, using the 
Randox kit, the colorimetric assay method for conjugated 
bilirubin employed involved reaction with diazotized 
sulphanilic acid in alkaline medium to form a blue complex, 
while total bilirubin was determined in the presence of 
caffeine, which releases albumin-bound bilirubin that then 
reacts with diazotized sulphanilic acid[17].
2.11. Determination of packed cell volume
   Whole blood samples were collected into heparinized 
capillary tubes, filled up to about 2/3 the length, sealed with 
plasticine and centrifuged at 3 000 r/min for 10 min. The 
packed cell volume (PCV) was determined using hematocrit 
reader, and the hemoglobin concentration was calculated 
from the PCV values[18]. 
2.12. Determination of total and high-density lipoprotein 
(HDL)-cholesterol
   The method of Roeschlau and Gruber was applied using 
assay kits (Randox Laboratories Ltd., UK) to determine 
the total serum cholesterol spectrophotometrically at 546 
nm following enzymatic hydrolysis and oxidation[19]. The 
HDL-cholesterol was determined using assay kits (Randox 
Laboratories Ltd., UK) after low density lipoprotein (LDL 
and VLDL) and chylomicron fractions were precipitated 
quantitatively by the addition of phosphotungstic acid 
in the presence of magnesium ions. After centrifugation, 
the cholesterol concentration in the HDL fraction in the 
supernatant was assayed colorimetrically at 540 nm[19]. 
2.13. Statistical analysis
   The results obtained were statistically analyzed using 
analysis of variance (ANOVA) followed by Duncan’s multiple 
range test (DMRT) to separate the means with significant 
differences. The level of significance was set at P<0.05. 
3. Results 
   
   The diabetic groups treated with either the methanolic 
extract of T. tetraptera leaf or the standard anti-diabetic 
drug, glibenclamide showed significant percentage change 
(P<0.05) in the fasting blood sugar level (30.15% and 47.56%, 
respectively) compared to the diabetic (0.59%) and normal 
controls (2.30%) between Day 0 and Day 7 (Figure 1). 
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Figure 1.  Percentage change in FBS in alloxan-induced diabetic rats treated 
with methanolic extract of T. tetraptera leaves (50 mg/kg) for 7 d.
FBS: fasting blood sugar.
   Whereas other groups, including the diabetic group 
treated with either the methanolic extract of T. tetraptera 
leaves or the standard drug experienced positive growth, 
which were increases in absolute weight, the untreated 
diabetic group experienced more than 11% decrease in 
weight (Figure 2). However, no statistical difference (P>0.05) 
was observed in the percentage organ to body weight ratio 
for the liver, kidney and heart between the treated groups 
and the control groups (Figure 3). Figure 4 shows AST and 
ALT activities while Table 1 shows the bilirubin levels in 
the serum of treated animals and control. There was a 
statistically significant (P<0.05) elevation in the activities 
of the liver enzymes, AST and ALT, as well as in the levels 
of total and direct bilirubin in the diabetic control rats 
compared to normal control group, but treatment with 
the methanolic extract of T. tetraptera leaves (50 mg/kg) 
significantly prevented the elevation of these indices of 
liver function in the diabetic rats. 
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Figure 2. Percentage change in weight in alloxan-induced diabetic rats 
treated with methanolic extract of T. tetraptera leaves (50 mg/kg) for 7 d.
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Figure 3. Percentage of organ and body weight ratio in alloxan-induced 
diabetic rats treated with methanolic extract of T. tetraptera leaves (50 mg/kg) 
for 7 d.
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Figure 4. Activities of AST and ALT in alloxan-induced diabetic rats treated 
with methanolic extract of T. tetraptera leaves (50 mg/kg) for 7 d.
25
20
15
10
  5
  0
A
ct
iv
it
y 
(U
/L
)
Normal control Diabetic control Diabetic+Std drug T. tetraptera only
Treatment
AST ALT
Diabetic+T. 
tetraptera
Table 1
Total and direct bilirubin levels in alloxan-induced diabetic rats 
treated with methanolic extract of T. tetraptera leaves (50 mg/kg) for 7 
d.
Treatment
Total bilirubin 
(µmol/L)
Direct bilirubin 
(µmol/L)
Normal control 2.46依0.07a    6.56依0.12ab
Diabetic control 8.01依0.18b 10.20依0.35b
Diabetic+Std drug 6.16依0.16 b   7.20依0.25ab
T. tetraptera only  5.55依0.12ab  5.38依0.13a
Diabetic+T. tetraptera 6.16依0.16b   8.20依0.21ab
Data with different superscript letters along the same column are 
statistically different (P<0.05).
   It was also observed that the T. tetraptera leaf extract 
was more effective in managing these conditions than the 
standard drug, glibenclamide at the recommended dose of 
1 mg/kg. There was also a significant (P<0.05) reduction in 
PCV in diabetic rats compared to the control (Figure 5), but 
extract treatment significantly improved the condition to a 
level that was not statistically different (P>0.05) from that of 
the normal group. The standard drug exhibited more potency 
in improving hematological parameters than the T. tetraptera 
extract. In general, there was no statistically significant 
(P>0.05) difference observed in levels of hemoglobin 
concentration between the groups (Figure 5). 
Figure 5. Levels of some hematological parameters in alloxan-induced 
diabetic rats treated with methanolic extract of T. tetraptera leaves (50 mg/kg) 
for 7 d.
C
on
ce
nt
io
n/
%
Treatment
PCV(%) Hb (g/100 mL)
60
50
40
30
20
10
  0
Normal control Diabetic control Diabetic+Std drug T. tetraptera only Diabetic+T. 
tetraptera
   The levels of MDA in the liver, kidneys and heart are 
shown in Table 2. Compared with the untreated control, the 
highest significant elevation in the levels of MDA was found 
in the organs of the diabetic group of rats with the kidneys. 
However, extract treatment significantly (P<0.05) lowered 
MDA levels in all the treated groups.
Table 2
MDA levels in major organs of alloxan-induced diabetic rats treated 
with methanolic extract of T. tetraptera leaves (50 mg/kg) for 7 d.
Treatment
TBARS (nmoL/mg protein)
Liver   Kidney Heart
Normal control 0.02依0.01a 0.12依0.01a 0.06依0.00a
Diabetic control 0.18依0.01c 0.23依0.01c 0.18依0.01c
Diabetic+Std drug 0.08依0.00b  0.14依0.00ab 0.07依0.04a
T. tetraptera only  0.11依0.01bc 0.11依0.01a 0.07依0.00a
Diabetic+T. tetraptera 0.10依0.01b 0.17依0.01b 0.13依0.01c
Data with different superscript letters along the same column are 
statistically different (P<0.05); TBARS=thiobarbituric acid reactive 
substances. 
 
   Tables 3 and 4 present the activities of the endogenous 
antioxidant enzymes in the major organs of the control and 
treated animals. 
Table 3
SOD activity in major organs of alloxan-induced diabetic rats treated 
with methanolic extract of T. tetraptera leaves (50 mg/kg) for 7 d.
Treatment
                SOD activity (µ/mg protein)
    Liver                Kidney             Heart
Normal control  39.27依1.13bc 23.01依1.10b 26.99依1.10b
Diabetic control 25.81依0.95a 17.04依0.66a 21.04依1.02a
Diabetic+Std drug  30.20依2.04ab 21.84依0.91b 25.46依1.20b
T. tetraptera only 42.08依1.50c 30.94依1.62c 35.04依2.01c
Diabetic+T. tetraptera  34.03依2.12bc 21.50依1.15b 25.02依1.25b
Data with different superscript letters along the same column are 
statistically different (P<0.05).
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Table 4
CAT activity in major organs of alloxan-induced diabetic rats treated 
with methanolic extract of T. tetraptera leaves (50 mg/kg) for 7 d.
Treatment
             CAT activity (µ/mg protein)
Liver Kidney Heart
Normal control 16.16依0.95c  13.79依0.46bc 14.09依0.55c
Diabetic control 11.72依0.40a  9.15依0.39a  9.19依0.36a
Diabetic+Std drug  16.74依0.43bc  16.01依0.56bc  12.25依0.44ab
T. tetraptera only 21.11依0.94c 21.56依0.68c 14.09依0.55c
Diabetic+T. tetraptera 17.76依0.92b 13.72依0.52b 12.25依0.44b
Data with different superscript letters along the same column are 
statistically different (P<0.05). 
   In all organs considered, there was a significant (P<0.05) 
reduction in activity of CAT and SOD in diabetic rats when 
compared to the non-diabetic control rats. Treatment of 
the diabetic rats with the methanolic extract of T. tetraptera 
leaves was able to restore the activities of the enzymes in 
all the organs to the normal range, except in the heart. It 
was worthy to note that SOD activity was generally higher in 
the heart than kidney tissues.
   There was a significant (P<0.05) elevation in total 
cholesterol level with concomitant lowered HDL level in 
diabetic rats compared to the non-diabetic control (Figure 
6), but in diabetic control groups treated with T. tetraptera, 
the HDL level was raised to a level that was statistically not 
different from that of the normal control. In all these lipid 
parameters. There was no statistically significant difference 
between the group treated with the extract and that treated 
with the standard control, glibenclamide (Figure 6).
Figure 6. Lipid profile in alloxan-induced diabetic rats treated with 
methanolic extract of T. tetraptera leaves (50 mg/kg) for 7 d.
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   Diabetic condition caused a doubling in the level of urea 
and a significant (P<0.05) elevation in the concentration 
of creatinine compared to that of the normal control, but 
treatment with the methanolic extract of T. tetraptera leaves 
reduced the level to a value insignificantly different from 
that of the normal control group (Figure 7). Even in non-
diabetic control, extract administration significantly (P<0.05) 
reduced the serum urea and, to a large extent, the creatinine 
levels.
Figure 7. Levels of some renal function parameters in alloxan-induced 
diabetic rats treated with methanolic extract of T. tetraptera leaves (50 mg/kg) 
for 7 d.
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4. Discussion 
4.1. Effect on weight changes and fasting blood sugar
   Diabetes is now recognized as one of the major killer 
diseases and a leading cause of death, claiming many lives 
world over[1]. Oral hypoglycemic agents, especially the 
sulphonylureas and biguanides, have been commonly used 
in the management of the disease, especially type II diabetes, 
although they have serious side effects. Consequently, 
attention has been focused on the use of plants and herbal 
remedies believed to be safer and devoid of serious side 
effects as alternatives in the treatment of diabetes[2,4,20]. 
The significant low blood sugar level in diabetic rats by 
administration of the methanolic extract of T. tetraptera 
leaf confirms that it could serve as a more accessible and 
affordable alternative to orthodox antidiabetics.
   The positive weight change observed in the diabetic animals 
treated with the extract or the standard drug clearly suggested 
that T. tetraptera might be useful in managing dysfunctional 
lipid metabolism, which is one of the undesirable side effects 
encountered when treating diabetics with sulphonylureas[20]. 
The non-significant changes in organ to weight ratio between 
the treated and normal control suggested that administration 
of methanol extract of T. tetraptera leaves had little or no 
toxic effect in the treated animals. The T. tetraptera extract 
apparently decreased plasma glucose levels in diabetic rats 
than the standard drug, glibenclamide at the recommended 
dose seems to suggest that T. tetraptera has the capacity to 
reduce the risk of other complications associated with people 
suffering with diabetes[21], and hence validates its local use 
as a hypoglycemic agent by the Igala people of north central 
Nigeria.
4.2. Effect of T. tetraptera leaf extract on hepatocellular and 
oxidative damage
   Damage to hepatic tissues mainly releases the enzymes 
AST and ALT from the hepatic cells into the plasma, and, 
hence, elevation of plasma activities of these enzymes is 
considered a reliable indicator of liver damage, since these 
enzymes are intracellular[22]. That treatment of alloxan-
diabetic rats with methanolic extract of T. tetraptera leaves 
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significantly (P<0.05) reduced their elevated levels of 
AST and ALT activities, suggesting that the plant contains 
substances (polyphenols) that are capable of protecting and 
alleviating liver damage. Also, in diabetic rats treated with 
methanolic extract of T. tetraptera leaves, the levels of PCV 
and hemoglobin concentration were greatly improved, while 
the elevations in the levels of total and direct bilirubin were 
significantly reduced. The results suggest that T. tetraptera 
leaf extract contains compounds possessing antioxidant 
properties, judging from its effect on MDA level, which may 
provide oxidative stability for membranes of red blood cells 
and hepatic tissues. 
   Lipid peroxidation is considered to be a primary mechanism 
of cell membrane destruction by free radicals because MDA 
conjugates with amino group of proteins to form intra- and 
inter-molecular cross-links that inactivate the membrane-
bound enzymes and receptors[23]. Hence, the administration 
of methanolic extract of T. tetraptera leaves significantly 
(P<0.05) reduced the level of MDA in diabetic rats, which 
strongly suggests the ability of the plant and its constituents 
to prevent oxidative damage, probably by interfering with the 
free radical-induced processes, leading to intra- and inter-
molecular cross-linkages. 
   Superoxide anion radical (O2.-), hydrogen peroxide (H2O2) 
and hydroxyl radical (OH*), which are the major reactive 
oxygen species, generated during oxidative stress are 
known to decrease insulin receptor substrate and tyrosine 
phosphorylation, and, thus, the activity of phosphatidyl 
inositol-3-kinase leads to insulin resistance, a major 
feature of type 2 diabetes[24]. Fortunately, aerobic cells are 
endowed with extensive antioxidant defense mechanisms, 
including low-molecular weight scavengers such as reduced 
glutathione, ascorbic acid, vitamin E and endogenous 
antioxidant enzyme system such as CAT, SOD and glutathione 
peroxidase. In this investigation, diabetes-induced depletion 
in the activities of SOD and CAT, possibly due to less 
availability of NADPH or gradual decrease in erythrocyte CAT 
activity through excessive generation of O2
** that inactivates 
the enzyme, was significantly ameliorated by administration of 
the methanolic extract of T. tetraptera leaves, suggesting that 
the plant contains antioxidant phytochemicals such as vitamin 
E and polyphenols that can significantly boost the activity of 
these endogenous antioxidant enzymes[24,25]. 
4.3. Effect of T. tetraptera leaf extract on lipid profile and renal 
function parameters
   The low plasma total cholesterol and the significant increase 
in HDL-cholesterol level in the treated animals compared 
with the untreated diabetic rats clearly demonstrates the 
presence of hypolipidemic agents in the methanol extract 
of T. tetraptera leaves. The ability of the extract to manage 
dyslipidemia is a potential beneficial effect on cardiovascular 
disorders, an associated diabetic complication that is a 
major cause of death among diabetics[26,27]. The diabetic 
condition caused a significant (P<0.05) increase in plasma 
creatinine and urea levels which could be a sign of impaired 
renal function that was restored to the normal range through 
treatment with methanolic extract of T. tetraptera leaves[27]. 
This finding demonstrates the therapeutic importance of the 
plant in the management of chronic glomerular disease, one of 
the complications of diabetes that is associated with elevated 
levels of blood urinary nitrogen and creatinine[28]. Further 
studies are required to identify and elucidate the exact 
constituents in T. tetraptera leaves that are responsible for the 
observed pharmacological and therapeutic activities. 
   The present study validates the use of T. tetraptera leaf in 
Igala traditional medicine and demonstrates that the methanol 
extract of the plant contains phytochemicals that exhibits 
very impressive potency and promise in the management of 
diabetes and its complications. 
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Comments 
Background
   Diabetes mellitus is a debilitating disease, which is a 
leading cause of death in the world. Measures aimed at 
improving the current management of the disease, and its 
complications, through herbal interventions are pertinent 
and highly promising. Some studies conducted earlier have 
shown that extracts of T. tetraptera possess antioxidant and 
hypoglycaemic activities, indicating that the extracts may 
be of value in the management of diabetes mellitus and its 
associated complications. 
  
Research frontiers
   The study was carried out in order to determine the 
effect of methanol extract of the leaves of T. tetraptera on 
hyperglycaemia and some markers of oxidative stress in rats 
induced with diabetes mellitus. The extract reduced tissue 
concentrations of biomarkers of oxidative stress, including 
malondialdehyde, increased catalase and superoxide 
dismutase activities, and alleviated other complications 
associated with diabetes, without any side-effect on the 
kidneys and liver in rats. It was a promising search for natural, 
less toxic and yet readily available phytochemical compounds 
that may be used for the management of the disease. The work 
has demonstrated that the extract contains potent antioxidants 
and hypoglycaemic agents. If isolated, the active constituents 
in the extract may be added to the arsenal of drugs currently 
used to treat diabetes. 
Related reports
   The results of the study agree with the findings of previous 
studies (Aladesanmi, 2007; Odesanmi et al., 2011) that extracts 
of the plant contain chemical constituents, possessing potent 
activities which are of value in the treatment of diseases. 
Innovations and breakthroughs
   There is paucity of information on the use of the extract of 
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the plant, T. tetraptera in the treatment of diabetes mellitus. 
Studies on the alleviating role of the leaf extract of plants, 
including T. tetraptera in complications associated with 
diabetes are currently lacking in the available literature. The 
present study has shown that the extract may be used not 
only in the therapy of diabetes, but also in the management of 
complications due to the disease, including oxidative stress 
and hyperlipidaemia. 
  
Applications
   The biochemical parameters measured in the present study 
are important markers of oxidative stress and liver function. 
They may be used to determine the responses of diabetic 
individuals with or without complications to phytomedicine. 
The plant extract may be a cheap and readily available source 
of compounds possessing active principles in the management 
of diabetes mellitus. 
Peer review
   This is an interesting study carried out by the authors on 
the effect of methanol leaf extract of T. tetraptera on diabetes 
mellitus. The study has shown that the extract contains 
potent chemical constituents, which exert antioxidant and 
hypoglycaemic effects. The extract may be beneficial in 
the treatment of diabetes and its complications, including 
hyperlipidaemia.
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